Katarzyna Kozak

754 total citations
57 papers, 453 citations indexed

About

Katarzyna Kozak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Katarzyna Kozak has authored 57 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Katarzyna Kozak's work include Melanoma and MAPK Pathways (16 papers), Sarcoma Diagnosis and Treatment (16 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Katarzyna Kozak is often cited by papers focused on Melanoma and MAPK Pathways (16 papers), Sarcoma Diagnosis and Treatment (16 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Katarzyna Kozak collaborates with scholars based in Poland, Hungary and Italy. Katarzyna Kozak's co-authors include Piotr Rutkowski, Hanna Koseła-Paterczyk, Tomasz Świtaj, Sławomir Falkowski, Anna M. Czarnecka, Iwona Ługowska, Aneta Borkowska, Anna Klimczak, Mateusz Spałek and Paweł Teterycz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Katarzyna Kozak

50 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarzyna Kozak Poland 12 209 165 164 66 46 57 453
Nagla Abdel Karim United States 13 286 1.4× 194 1.2× 184 1.1× 56 0.8× 52 1.1× 61 634
Lu Yu China 16 383 1.8× 158 1.0× 109 0.7× 124 1.9× 38 0.8× 48 685
Felipe G. Gercovich Argentina 7 218 1.0× 83 0.5× 101 0.6× 86 1.3× 107 2.3× 29 439
Anna Maria Mosconi Italy 13 364 1.7× 140 0.8× 90 0.5× 134 2.0× 59 1.3× 39 558
Birgit Helmchen Switzerland 14 122 0.6× 144 0.9× 166 1.0× 108 1.6× 111 2.4× 38 497
Adarsh Joshi United States 10 170 0.8× 188 1.1× 119 0.7× 88 1.3× 141 3.1× 19 633
Philippe C. Bishop United States 12 166 0.8× 110 0.7× 100 0.6× 48 0.7× 146 3.2× 17 499
Chiung‐Ru Lai Taiwan 14 151 0.7× 118 0.7× 47 0.3× 64 1.0× 41 0.9× 24 504
Smitha Menon United States 11 300 1.4× 134 0.8× 128 0.8× 73 1.1× 32 0.7× 18 474
Eric Himmelfarb United States 10 146 0.7× 160 1.0× 161 1.0× 92 1.4× 26 0.6× 14 458

Countries citing papers authored by Katarzyna Kozak

Since Specialization
Citations

This map shows the geographic impact of Katarzyna Kozak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Kozak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Kozak more than expected).

Fields of papers citing papers by Katarzyna Kozak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Kozak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Kozak. The network helps show where Katarzyna Kozak may publish in the future.

Co-authorship network of co-authors of Katarzyna Kozak

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Kozak. A scholar is included among the top collaborators of Katarzyna Kozak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Kozak. Katarzyna Kozak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rutkowski, Piotr, Anna Klimczak, Paweł Teterycz, et al.. (2025). Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer. 225. 115565–115565.
2.
Czarnecka, Anna M., Anna Szumera‐Ciećkiewicz, Tomasz Świtaj, et al.. (2024). Long‐term efficacy of neoadjuvant–adjuvant targeted therapy in borderline resectable stage IIIB–D and IV melanoma. Cancer. 130(20). 3463–3472. 1 indexed citations
3.
Kozak, Katarzyna, Paweł Sobczuk, Tomasz Świtaj, et al.. (2023). 1987TiP Pembrolizumab in combination with eftilagimod alpha and radiotherapy in neoadjuvant treatment of patients with soft tissue sarcomas: EFTISARC-NEO trial. Annals of Oncology. 34. S1059–S1059.
4.
Kozak, Katarzyna, et al.. (2023). Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application. Journal of Cancer Research and Clinical Oncology. 149(19). 17635–17649. 5 indexed citations
5.
Sobczuk, Paweł, et al.. (2022). In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma. Journal of Cancer Research and Clinical Oncology. 149(7). 2771–2782. 3 indexed citations
6.
Sobczuk, Paweł, Katarzyna Kozak, Tomasz Świtaj, et al.. (2022). Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study. Cancers. 14(2). 422–422. 3 indexed citations
7.
Czarnecka, Anna M., Paweł Sobczuk, Tomasz Świtaj, et al.. (2022). Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence. Cancer Immunology Immunotherapy. 71(8). 1949–1958. 13 indexed citations
8.
Czarnecka, Anna M., Bożena Cybulska-Stopa, Marcin Ziętek, et al.. (2022). Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. Cancers. 14(9). 2123–2123. 5 indexed citations
9.
Sobczuk, Paweł, Katarzyna Kozak, Tomasz Świtaj, et al.. (2022). The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma. Cancers. 14(3). 777–777. 8 indexed citations
10.
Raciborska, Anna, Hanna Koseła-Paterczyk, Katarzyna Kozak, et al.. (2021). Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience. Journal of Clinical Medicine. 10(16). 3627–3627. 8 indexed citations
11.
Czarnecka, Anna M., Aneta Borkowska, Anna Szumera‐Ciećkiewicz, et al.. (2021). Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma. Cancers. 14(1). 110–110. 11 indexed citations
12.
Sobczuk, Paweł, Paweł Teterycz, Anna M. Czarnecka, et al.. (2020). Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience. Journal of Clinical Medicine. 9(10). 3157–3157. 20 indexed citations
13.
Kozak, Katarzyna, Paweł Teterycz, Tomasz Świtaj, et al.. (2020). The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma. Journal of Clinical Medicine. 9(10). 3129–3129. 3 indexed citations
14.
Kozak, Katarzyna, Artur Kowalik, Bartosz Wasąg, et al.. (2020). Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis. Tumori Journal. 106(3). 241–248. 14 indexed citations
15.
Rutkowski, Piotr, et al.. (2019). Management of brain metastases in melanoma. Oncology in Clinical Practice. 15(1). 5 indexed citations
16.
Koseła-Paterczyk, Hanna, et al.. (2018). The use of vismodegib in the treatment of basal cell carcinoma based on case reports. Oncology in Clinical Practice. 14(2). 104–109. 1 indexed citations
17.
Pieńkowski, Andrzej, Anna Szumera‐Ciećkiewicz, Hanna Koseła-Paterczyk, et al.. (2017). [The long-term treatment outcomes of adult osteosarcoma].. PubMed. 42(250). 158–164. 6 indexed citations
18.
Kozak, Katarzyna, et al.. (2016). Anxiety associated with parachute jumping as the cause of blood red-ox balance impairment. Psychiatria Polska. 50(6). 1235–1250.
19.
Koseła-Paterczyk, Hanna, et al.. (2015). Przypadki kliniczne chorych na zaawansowane czerniaki leczonych ipilimumabem. Oncology in Clinical Practice. 11. 1 indexed citations
20.
Rutkowski, Piotr, Marcin Zdzienicki, & Katarzyna Kozak. (2014). Subcutaneous Metastases from Melanoma: a Discussion of Clinical Experience. PubMed. 1(1). 31–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagla Abdel Karim Breakdown of academic impact, for papers by Lu Yu Breakdown of academic impact, for papers by Felipe G. Gercovich Breakdown of academic impact, for papers by Anna Maria Mosconi Breakdown of academic impact, for papers by Birgit Helmchen Breakdown of academic impact, for papers by Adarsh Joshi Breakdown of academic impact, for papers by Philippe C. Bishop Breakdown of academic impact, for papers by Chiung‐Ru Lai Breakdown of academic impact, for papers by Smitha Menon Breakdown of academic impact, for papers by Eric Himmelfarb
Rankless by CCL
2026